Davidson Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1
Closed -$90 81
2025
Q1
$90 Sell
1
-33,611
-100% -$3.14M ﹤0.01% 80
2024
Q4
$3.34M Buy
33,612
+6,318
+23% +$651K 0.88% 31
2024
Q3
$3.1M Buy
27,294
+3,165
+13% +$376K 0.89% 34
2024
Q2
$2.99M Buy
24,129
+2,829
+13% +$364K 0.92% 38
2024
Q1
$2.81M Buy
21,300
+224
+1% +$27.6K 0.9% 25
2023
Q4
$2.3M Buy
21,076
+6,582
+45% +$683K 0.83% 40
2023
Q3
$1.49M Sell
14,494
-77
-0.5% -$8.3K 0.74% 37
2023
Q2
$1.68M Buy
14,571
+142
+1% +$16.1K 0.84% 20
2023
Q1
$1.54M Sell
14,429
-1,315
-8% -$142K 0.93% 16
2022
Q4
$1.75M Sell
15,744
-39
-0.2% -$3.99K 1.2% 6
2022
Q3
$1.36M Buy
15,783
+686
+5% +$61.2K 0.67% 13
2022
Q2
$1.38M Sell
15,097
-3,972
-21% -$352K 0.65% 12
2022
Q1
$1.56M Buy
19,069
+1,768
+10% +$139K 0.58% 13
2021
Q4
$1.33M Buy
17,301
+707
+4% +$56.3K 0.73% 51
2021
Q3
$1.25M Buy
16,594
+612
+4% +$46.5K 0.63% 43
2021
Q2
$1.24M Buy
15,982
+1,283
+9% +$95.4K 0.6% 43
2021
Q1
$1.08M Sell
14,699
-5,384
-27% -$397K 0.56% 61
2020
Q4
$1.57M Buy
20,083
+678
+3% +$51.9K 0.88% 20
2020
Q3
$1.54M Buy
+19,405
New +$1.52M 0.97% 19

Other funds holding MRK

Davidson Capital Management's MRK Position: Q2 2025 in Review

Davidson Capital Management sold out of Merck (MRK) in Q2 2025, closing a stake of 1 share — an estimated $90 sold.

Davidson Capital Management first reported a position in MRK in Q3 2020 and held it in 19 quarters. The position peaked at $3.34M in Q4 2024. 3,328 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Davidson Capital Management reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Davidson Capital Management sold 1 Merck share in Q2 2025, an estimated $90.
  • Davidson Capital Management first reported a position in Merck in Q3 2020 and held it in 19 quarters.
  • Davidson Capital Management's Merck position peaked at $3.34M in Q4 2024.
  • 3,328 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Davidson Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.